Should You Participate in a Cancer Clinical Trial? Dr. Amy Leader & Dr. Ronald Myers Discuss

5
Aug

Jefferson’s Amy Leader, DrPH, MPH, and Ronald Myers, PhD, of the Division of Population Science, Department of Medical Oncology, have created a tool to help patients come to terms with their own fears and preconceptions about clinical trials, in order to help them make informed decisions about their care.
A recent Philadelphia Inquirer story featured commentary from Jefferson about how important it is for more patients to participate in clinical trials for cancer. Research drives the development of new therapies for all — in other words, without clinical trials there would be no new treatments. While many patients decry how long it takes for new drugs to be developed, one component of that timeline is how long it takes for clinical trials to accrue enough patients to make meaningful conclusions of the data.
On the other hand, there are good reasons that patients hesitate.
A “Q and A” with Jefferson faculty members provides insights. Jefferson’s Amy Leader, DrPH, MPH, Assistant Professor, Division of Population Science, Department of Medical Oncology and Ronald Myers, PhD, Professor and Director, Division of Population Science, Department of Medical Oncology, have created a tool to help patients come to terms with their own fears and preconceptions about clinical trials, in order to help them make informed decisions about their care.
See the Q and A published earlier this month in the @Jeff blog.